Introduction: Constipation is common in patients with Parkinson’s disease (PD), but its impact on incident PD remains uncertain. We aimed to prospectively investigate constipation symptoms and the risk of PD. Methods: Participants without PD at baseline from the UK Biobank were included in the study. Information on the regular use of laxatives, bowel movement frequency, and the frequency of hard or lumpy stools was collected. Incident PD was defined by the ICD-10 code. Cox proportional hazards models were used to assess the association between constipation symptoms and incident PD. Results: In the analysis of regular laxative use and PD, 490,797 participants were included and 2,735 incident PD were detected. The multivariable adjusted HR of PD in participants who regularly used laxatives was 1.99 (95% confidence interval [CI], 1.70–2.33) compared with those who did not. In the analysis of bowel movement frequency and hard or lumpy stools and PD, 170,017 participants were included and 519 incident PD were detected. The multivariable adjusted HRs were 2.16 (95% CI, 1.74–2.68) and 2.57 (95% CI, 2.00–3.31) for participants with a bowel movement frequency of 3–6 times/week and <3 times/week, respectively, compared with those with a bowel movement frequency of ≥7 times/week; compared with participants who never had hard or lumpy stools, multivariable adjusted HRs were 1.31 (95% CI, 1.07–1.60), 2.32 (95% CI, 1.77–3.05), and 2.94 (95% CI, 2.14–4.05) for those who sometimes had hard or lumpy stools, often had hard or lumpy stools, and most of time/always had hard or lumpy stools, respectively. Conclusions: Constipation measured by the regular use of laxatives, bowel movement frequency, and the frequency of hard or lumpy stools was significantly associated with an increased risk of incident PD.

1.
Jankovic
J
.
Parkinson’s disease: clinical features and diagnosis
.
J Neurol Neurosurg Psychiatry
.
2008
;
79
(
4
):
368
76
.
2.
Goetz
CG
,
Pal
G
.
Initial management of Parkinson’s disease
.
BMJ
.
2014
;
349
:
g6258
.
3.
Tolosa
E
,
Garrido
A
,
Scholz
SW
,
Poewe
W
.
Challenges in the diagnosis of Parkinson's disease
.
Lancet Neurol
.
2021
;
20
(
5
):
385
97
.
4.
Dorsey
ER
,
Constantinescu
R
,
Thompson
JP
,
Biglan
KM
,
Holloway
RG
,
Kieburtz
K
, et al
.
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
.
Neurology
.
2007
;
68
(
5
):
384
6
.
5.
Aarsland
D
,
Batzu
L
,
Halliday
GM
,
Geurtsen
GJ
,
Ballard
C
,
Ray Chaudhuri
K
, et al
.
Parkinson disease-associated cognitive impairment
.
Nat Rev Dis Primers
.
2021
;
7
(
1
):
47
.
6.
GBD 2016 Neurology Collaborators
.
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
.
Lancet Neurol
.
2019
;
18
(
5
):
459
80
.
7.
Bloem
BR
,
Okun
MS
,
Klein
C
.
Parkinson’s disease
.
Lancet
.
2021
;
397
(
10291
):
2284
303
.
8.
The
LN
.
Parkinson’s disease needs an urgent public health response
.
Lancet Neurol
.
2022
;
21
(
9
):
759
.
9.
Schrag
A
,
Bohlken
J
,
Dammertz
L
,
Teipel
S
,
Hermann
W
,
Akmatov
MK
, et al
.
Widening the spectrum of risk factors, comorbidities, and prodromal features of Parkinson disease
.
JAMA Neurol
.
2023
;
80
(
2
):
161
71
.
10.
de Lau
LM
,
Breteler
MM
.
Epidemiology of Parkinson’s disease
.
Lancet Neurol
.
2006
;
5
(
6
):
525
35
.
11.
Kalia
LV
,
Lang
AE
.
Parkinson’s disease
.
Lancet
.
2015
;
386
(
9996
):
896
912
.
12.
Postuma
RB
,
Aarsland
D
,
Barone
P
,
Burn
DJ
,
Hawkes
CH
,
Oertel
W
, et al
.
Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson's disease
.
Mov Disord
.
2012
;
27
(
5
):
617
26
.
13.
Stocchi
F
,
Torti
M
.
Constipation in Parkinson’s disease
.
Int Rev Neurobiol
.
2017
;
134
:
811
26
.
14.
Locke
GR
3rd
,
Pemberton
JH
,
Phillips
SF
.
AGA technical review on constipation. American Gastroenterological Association
.
Gastroenterology
.
2000
;
119
(
6
):
1766
78
.
15.
Higgins
PD
,
Johanson
JF
.
Epidemiology of constipation in North America: a systematic review
.
Am J Gastroenterol
.
2004
;
99
(
4
):
750
9
.
16.
Dennison
C
,
Prasad
M
,
Lloyd
A
,
Bhattacharyya
SK
,
Dhawan
R
,
Coyne
K
.
The health-related quality of life and economic burden of constipation
.
Pharmacoeconomics
.
2005
;
23
(
5
):
461
76
.
17.
Koloski
NA
,
Jones
M
,
Wai
R
,
Gill
RS
,
Byles
J
,
Talley
NJ
.
Impact of persistent constipation on health-related quality of life and mortality in older community-dwelling women
.
Am J Gastroenterol
.
2013
;
108
(
7
):
1152
8
.
18.
Abbott
RD
,
Petrovitch
H
,
White
LR
,
Masaki
KH
,
Tanner
CM
,
Curb
JD
, et al
.
Frequency of bowel movements and the future risk of Parkinson’s disease
.
Neurology
.
2001
;
57
(
3
):
456
62
.
19.
Abbott
RD
,
Ross
GW
,
Petrovitch
H
,
Tanner
CM
,
Davis
DG
,
Masaki
KH
, et al
.
Bowel movement frequency in late-life and incidental Lewy bodies
.
Mov Disord
.
2007
;
22
(
11
):
1581
6
.
20.
Gao
X
,
Chen
H
,
Schwarzschild
MA
,
Ascherio
A
.
A prospective study of bowel movement frequency and risk of Parkinson’s disease
.
Am J Epidemiol
.
2011
;
174
(
5
):
546
51
.
21.
Lin
CH
,
Lin
JW
,
Liu
YC
,
Chang
CH
,
Wu
RM
.
Risk of Parkinson’s disease following severe constipation: a nationwide population-based cohort study
.
Parkinsonism Relat Disord
.
2014
;
20
(
12
):
1371
5
.
22.
Simonet
C
,
Bestwick
J
,
Jitlal
M
,
Waters
S
,
Ben-Joseph
A
,
Marshall
CR
, et al
.
Assessment of risk factors and early presentations of Parkinson disease in primary care in a diverse UK population
.
JAMA Neurol
.
2022
;
79
(
4
):
359
69
.
23.
Collins
R
.
What makes UK Biobank special
.
Lancet
.
2012
;
379
(
9822
):
1173
4
.
24.
Sudlow
C
,
Gallacher
J
,
Allen
N
,
Beral
V
,
Burton
P
,
Danesh
J
, et al
.
UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age
.
PLoS Med
.
2015
;
12
(
3
):
e1001779
.
25.
Yao
L
,
Liang
W
,
Chen
J
,
Wang
Q
,
Huang
X
.
Constipation in Parkinson's disease: a systematic review and meta-analysis
.
Eur Neurol
.
2023
;
86
(
1
):
34
44
.
26.
Svensson
E
,
Henderson
VW
,
Borghammer
P
,
Horváth-Puhó
E
,
Sørensen
HT
.
Constipation and risk of Parkinson’s disease: a Danish population-based cohort study
.
Parkinsonism Relat Disord
.
2016
;
28
:
18
22
.
27.
Konings
B
,
Villatoro
L
,
Van den Eynde
J
,
Barahona
G
,
Burns
R
,
McKnight
M
, et al
.
Gastrointestinal syndromes preceding a diagnosis of Parkinson's disease: testing Braak’s hypothesis using a nationwide database for comparison with Alzheimer’s disease and cerebrovascular diseases
.
Gut
.
2023
;
72
(
11
):
2103
11
.
28.
Lehrer
S
,
Rheinstein
PH
.
Constipation and cigarette smoking are independent influences for Parkinson’s disease
.
Cureus
.
2022
;
14
(
1
):
e21689
.
29.
Khalif
IL
,
Quigley
EM
,
Konovitch
EA
,
Maximova
ID
.
Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation
.
Dig Liver Dis
.
2005
;
37
(
11
):
838
49
.
30.
Parthasarathy
G
,
Chen
J
,
Chen
X
,
Chia
N
,
O'Connor
HM
,
Wolf
PG
, et al
.
Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation
.
Gastroenterology
.
2016
;
150
(
2
):
367
79.e1
.
31.
Mancabelli
L
,
Milani
C
,
Lugli
GA
,
Turroni
F
,
Mangifesta
M
,
Viappiani
A
, et al
.
Unveiling the gut microbiota composition and functionality associated with constipation through metagenomic analyses
.
Sci Rep
.
2017
;
7
(
1
):
9879
.
32.
Li
H
,
Chen
J
,
Ren
X
,
Yang
C
,
Liu
S
,
Bai
X
, et al
.
Gut microbiota composition changes in constipated women of reproductive age
.
Front Cell Infect Microbiol
.
2020
;
10
:
557515
.
33.
Xu
YS
,
Wang
YH
,
Liu
Y
,
Sun
X
,
Xu
JS
,
Song
Y
, et al
.
Alteration of the faecal microbiota composition in patients with constipation: evidence of American Gut Project
.
Benef Microbes
.
2022
;
13
(
6
):
427
36
.
34.
Vriesman
MH
,
Koppen
IJN
,
Camilleri
M
,
Di Lorenzo
C
,
Benninga
MA
.
Management of functional constipation in children and adults
.
Nat Rev Gastroenterol Hepatol
.
2020
;
17
(
1
):
21
39
.
35.
Lai
H
,
Li
Y
,
He
Y
,
Chen
F
,
Mi
B
,
Li
J
, et al
.
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial
.
Gut Microbes
.
2023
;
15
(
1
):
2197837
.
36.
Tan
AH
,
Lim
SY
,
Lang
AE
.
The microbiome-gut-brain axis in Parkinson disease: from basic research to the clinic
.
Nat Rev Neurol
.
2022
;
18
(
8
):
476
95
.
37.
Sun
MF
,
Zhu
YL
,
Zhou
ZL
,
Jia
XB
,
Xu
YD
,
Yang
Q
, et al
.
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: gut microbiota, glial reaction and TLR4/TNF-α signaling pathway
.
Brain Behav Immun
.
2018
;
70
:
48
60
.
38.
Zhao
Z
,
Ning
J
,
Bao
XQ
,
Shang
M
,
Ma
J
,
Li
G
, et al
.
Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
.
Microbiome
.
2021
;
9
(
1
):
226
.
39.
Sampson
TR
,
Debelius
JW
,
Thron
T
,
Janssen
S
,
Shastri
GG
,
Ilhan
ZE
, et al
.
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease
.
Cell
.
2016
;
167
(
6
):
1469
80.e12
.
40.
St Germaine-Smith
C
,
Metcalfe
A
,
Pringsheim
T
,
Roberts
JI
,
Beck
CA
,
Hemmelgarn
BR
, et al
.
Recommendations for optimal ICD codes to study neurologic conditions: a systematic review
.
Neurology
.
2012
;
79
(
10
):
1049
55
.
41.
Hill
EJ
,
Sharma
J
,
Wissel
B
,
Sawyer
RP
,
Jiang
M
,
Marsili
L
, et al
.
Parkinson’s disease diagnosis codes are insufficiently accurate for electronic health record research and differ by race
.
Parkinsonism Relat Disord
.
2023
;
114
:
105764
.
You do not currently have access to this content.